Market Indices
Sector Heatmap
AMRX — Amneal Pharmaceuticals, Inc. Class A Common Stock
NasdaqAmneal Pharmaceuticals, Inc. Class A Common Stock
- O
- 20.19
- H
- 20.54
- L
- 20.00
- V
- 2.25M
AMRX — Latest News & Headlines
18 StoriesAmneal Pharmaceuticals, Inc. (AMRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Amneal Pharmaceuticals, Inc. (AMRX) Stock Price, News, Quote & History Yahoo! Finance Canada
AMRX Stock Price and Chart — NASDAQ:AMRX - TradingView
AMRX Stock Price and Chart — NASDAQ:AMRX TradingView
Why Is Amneal (AMRX) Stock Rocketing Higher Today - The Globe and Mail
Why Is Amneal (AMRX) Stock Rocketing Higher Today The Globe and Mail
Amneal Pharmaceuticals (NasdaqGS:AMRX) Stock Forecast & Analyst Predictions - Simply Wall Street
Amneal Pharmaceuticals (NasdaqGS:AMRX) Stock Forecast & Analyst Predictions Simply Wall Street
Amneal (NASDAQ: AMRX) director gifts 20,445 shares to trust he oversees - stocktitan.net
Amneal (NASDAQ: AMRX) director gifts 20,445 shares to trust he oversees stocktitan.net
Amneal: Even My Bull Case Barely Justifies $20/Share (NASDAQ:AMRX) - Seeking Alpha
Amneal: Even My Bull Case Barely Justifies $20/Share (NASDAQ:AMRX) Seeking Alpha
Why Is Amneal (AMRX) Stock Rocketing Higher Today - Yahoo Finance
Why Is Amneal (AMRX) Stock Rocketing Higher Today Yahoo Finance
Amneal Pharmaceuticals Inc (AMRX) Shares Surge 7.8% -- What GF S - GuruFocus
Amneal Pharmaceuticals Inc (AMRX) Shares Surge 7.8% -- What GF S GuruFocus
How AMRX Group (AMRX) Affects Rotational Strategy Timing - Stock Traders Daily
How AMRX Group (AMRX) Affects Rotational Strategy Timing Stock Traders Daily
Oppenheimer initiates Amneal Pharmaceuticals stock with outperform rating - Investing.com
Oppenheimer initiates Amneal Pharmaceuticals stock with outperform rating Investing.com
How Investors May Respond To Amneal Pharmaceuticals (AMRX) FDA Approval Launch - Simply Wall Street
How Investors May Respond To Amneal Pharmaceuticals (AMRX) FDA Approval Launch Simply Wall Street
A Look at Amneal Pharmaceuticals Inc (AMRX) After 3.7% Gain -- G - GuruFocus
A Look at Amneal Pharmaceuticals Inc (AMRX) After 3.7% Gain -- G GuruFocus
Amneal Pharmaceuticals stock gains after FDA approval for lanreotide injection - AD HOC NEWS
Amneal Pharmaceuticals stock gains after FDA approval for lanreotide injection AD HOC NEWS
Amneal Pharmaceuticals Director Kevin J. Buchi Transfers 20,445 Shares to Trust - Kalkine Media
Amneal Pharmaceuticals Director Kevin J. Buchi Transfers 20,445 Shares to Trust Kalkine Media
Oppenheimer Initiates Amneal Pharmaceuticals at Outperform With $27 Price Target - Yahoo Finance
Oppenheimer Initiates Amneal Pharmaceuticals at Outperform With $27 Price Target Yahoo Finance
Top Trulieve Cannabis (TRLV) Competitors 2026 - MarketBeat
Top Trulieve Cannabis (TRLV) Competitors 2026 MarketBeat
Amneal Pharmaceuticals (AMRX) Gains FDA Nod As Fair Value Sits Higher - Simply Wall Street
Amneal Pharmaceuticals (AMRX) Gains FDA Nod As Fair Value Sits Higher Simply Wall Street
How Investors May Respond To Amneal Pharmaceuticals (AMRX) Generic Lanreotide Launch - Simply Wall Street
How Investors May Respond To Amneal Pharmaceuticals (AMRX) Generic Lanreotide Launch Simply Wall Street